| Literature DB >> 27222353 |
Qi Zhao1, Yansheng Xue2, Yi Yang1, Zhibin Niu1, Changlin Wang1, Ying Hou1, Hui Chen1.
Abstract
Renal fibrosis, considered to be a common consequence of progressive renal disease, involves glomerulosclerosis and/or tubulointerstitial fibrosis. Currently, research is focused on investigating potential mechanisms to prevent or reverse the damage caused by fibrosis. Under the influence of cytokines, chemokines and other signaling molecules, the cellular interactions that regulate the development of interstitial fibrosis are complex. Epithelial‑mesenchymal transition (EMT) has emerged as an important pathway leading to the generation of matrix‑producing fibroblasts and myofibroblasts in diseased kidneys. The proteomics study compared the protein profiles between the time points of podocyte EMT and tubular cell EMT in a partial unilateral ureteral obstruction (PUUO) model in rats. Proteins isolated from the PUUO group and corresponding sham rat kidney tissues were subjected to 2‑D gel electrophoresis and were then identified by mass spectrometry. In total, 43 proteins with differential expression were identified, which were reported to be involved in the regulation of the cytoskeleton and actin, glucose metabolism, cell apoptosis, mitochondrial energy metabolism, oxidative stress and endoplasmic reticulum stress. Electron transfer flavoprotein, β polypeptide was detected by immunoblot analysis and its mRNA levels were determined in renal tissues. The results demonstrate protein alterations that reflect the pathology of the obstructed kidneys, and thus may aid in understanding the pathogenesis of obstructive nephropathy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27222353 PMCID: PMC4918607 DOI: 10.3892/mmr.2016.5338
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952
Figure 1Double immunofluorescence staining of neonatal PUUO (magnification, ×800). (A) PUUO1d: (A1) green labeling of podocalyxin in glomeruli; (A2) red labeling of ED-1; (A3) blue cell nuclei stained by DAPI; and (A4) merge. No phenotypic changes of the podocytes were observed in this group. (B) PUUO2d: (B1) green labeling of podocalyxin in glomeruli; (B2) red labeling of ED-1; (B3) blue cell nuclei stained by DAPI; (B4) merge. Podocytes exhibited mesenchymal characteristics (indicated by arrow). (C) PUUO5d: (C1) green labeling of E-cadherin in renal tubule; (C2) red labeling of α-smooth muscle actin; (C3) blue cell nuclei stained by DAPI; (C4) merge. Phenotypic changes in tubular epithelial cells were observed (indicated by arrow). PUUO, partial unilateral ureteral obstruction; PUUO1d, 1 days following PUUO; PUUO2d, 2 days following PUUO; PUUO5d, 5 days following PUUO.
Figure 22-DE of protein profiles of rat kidney tissues from the sham surgery group and the neonatal PUUO groups. Representative Coomassie-stained 2-DE gel expression maps of proteins in PUUO1d, PUUO2d, PUUO5d and sham surgery groups. 2-DE, 2-D electrophoresis; PUUO, partial unilateral ureteral obstruction; PUUO1d, 1 days following PUUO; PUUO2d, 2 days following PUUO; PUUO5d, 5 days following PUUO.
Proteins with differential expression between the PUUO groups and corresponding sham rat kidney tissues identified be matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
| Protein name | Accession no. | Mr (kDa)/Pi | Expression | Mascot score | Function |
|---|---|---|---|---|---|
| Hsp90b1 | IPI00365985 | 93/4.72 | 385 | Endoplasmic reticulum associated degradation | |
| Sucla2 | IPI00951645 | 48/6.08 | 125 | Tricarboxylic acid cycle | |
| Vcp | IPI00212014 | 90/5.14 | 478 | Export of misfolded proteins | |
| Acy1a | IPI00464791 | 46/6.03 | 437 | Amino acid metabolism | |
| Gsn | IPI00923716 | 81/5.46 | 152 | Actin-modulating protein | |
| Hnrnpf | IPI00210357 | 46/5.31 | 121 | Processing pre-mRNAs | |
| Cox5a | IPI00192246 | 16/6.08 | 116 | Oxidoreductase family | |
| RGD1565368 | IPI00769218 | 36/8.44 | 116 | Energy metabolism | |
| Ezr | IPI00470254 | 69/5.83 | 214 | Connection cytoskeletal structures to the plasma membrane | |
| Hnrnpk | IPI00780608 | 51/5.39 | 257 | Pre-mRNA-binding protein | |
| Tpm4 | IPI00214905 | 29/4.66 | 184 | Stabilize cytoskeleton actin filaments | |
| Aldh9a1 | IPI00203690 | 57/6.94 | 121 | Aldehyde dehydrogenase family | |
| Eef1b2 | IPI00476899 | 25/4.55 | 141 | EF-1-β/EF-1-α family | |
| Pepd | IPI00364304 | 56/5.61 | 100 | Collagen metabolism | |
| Prdx6 | IPI00231260 | 25/5.64 | 500 | Oxidoreductase family | |
| Dlst | IPI00551702 | 49/8.89 | 64 | Tricarboxylic acid cycle | |
| Park7 | IPI00212523 | 20/6.32 | 125 | Oxidoreductase family | |
| Actr3 | IPI00949517 | 48/5.61 | 229 | Actin polymerization and actin networks | |
| Rbm3 | IPI00367437 | 17/7.98 | 62 | Cold-inducible mRNA binding protein | |
| Psmc2 | IPI00421600 | 49/5.59 | 385 | Degradation of ubiquitinated proteins | |
| Erp44 | IPI00949066 | 47/5.14 | 244 | Protein folding | |
| Gdi2 | IPI00197568 | 47/6.5 | 140 | Regulate the GDP/GTP exchange | |
| Gsn | IPI00923716 | 81/5.46 | 86 | Actin-modulating protein | |
| Ahcy | IPI00476295 | 48/6.07 | 99 | Amino acid metabolism | |
| Ezr | IPI00948980 | 69/5.83 | 194 | Connection cytoskeletal structures to the plasma membrane | |
| Atp5b | IPI00551812 | 56/5.19 | 148 | Mitochondrial membrane ATP synthase | |
| RGD1309537 | IPI00564409 | 20/4.67 | 192 | Myosin regulatory subunit | |
| Fbp1 | IPI00231745 | 40/5.54 | 198 | Rate-limiting enzyme in gluconeogenesis | |
| Aldh1a2 | IPI00211419 | 57/5.58 | 186 | Aldehyde dehydrogenase family | |
| Clta | IPI00230870 | 24/4.43 | 160 | Clathrin light chain family | |
| Calr | IPI00191728 | 48/4.33 | 126 | Chaperone in protein folding | |
| Anxa5 | IPI00471889 | 36/4.93 | 440 | Anticoagulant protein | |
| Cct2 | IPI00366218 | 58/6.01 | 202 | Folding of actin | |
| Prdx1 | IPI00211779 | 22/8.27 | 75 | Oxidoreductase family | |
| Atp5b | IPI00551812 | 56/5.19 | 98 | Mitochondrial membrane ATP synthase | |
| Etfb | IPI00364321 | 28/7.6 | 150 | Specific electron acceptor | |
| Dld | IPI00365545 | 55/7.96 | 153 | Oxidoreductase family | |
| Tufm | IPI00371236 | 50/7.23 | 144 | Protein biosynthesis | |
| Ruvbl2 | IPI00364340 | 51/5.49 | 222 | Nucleotide-binding, ATP-binding, DNA repair | |
| LOC100360986 | IPI00559028 | 35/9.4 | 189 | Nucleic acid binding, nucleotide binding | |
| Tf | IPI00679202 | 79/7.14 | 461 | Stimulate cell proliferation | |
| Apoa4 | IPI00324272 | 44/5.12 | 62 | Chylomicrons and VLDL secretion and catabolism | |
| Aldh4a1 | IPI00921682 | 62/8.26 | 236 | Aldehyde dehydrogenase family |
upregulation of the protein level in the PUUO groups compared with the corresponding sham rat kidney tissues;
downregulation of the protein level in the PUUO groups compared with the corresponding sham rat kidney tissues. PUUO, partial unilateral ureteral obstruction.
Figure 3Immunoblot and RT-qPCR analysis of ETFB mRNA expression. (A) 2-DE gel of spot identified as ETFB (indicated by arrow). (B) Confirmation of 2-DE results by immunoblotting. Analysis of protein expression of ETFB with β-actin as the internal control. (C) Quantification of immunoblot result. Relative expression of ETFB protein. (D) Comparisons of total mRNA expression of ETFB by RT-qPCR. *P<0.05. 2-DE, 2-D electrophoresis; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; PUUO, partial unilateral ureteral obstruction; PUUO1d, 1 days following PUUO; PUUO2d, 2 days following PUUO; PUUO5d, 5 days following PUUO; ETFB, electron transfer flavoprotein, β polypeptide.